Does Laser Therapy Really Help Arthritis?

Laser therapy for arthritis occupies a frustrating middle ground: it is neither the miracle that some clinics advertise nor the quackery that skeptics dismiss. Pooled data from randomized trials show that low-level laser therapy can produce real, measurable reductions in joint pain and stiffness beyond what placebo achieves, but the size of the benefit depends heavily on the type of arthritis, the dose of light delivered, and the specific joint being treated. The story gets more interesting when you look at why the results are so inconsistent from study to study, and why major clinical guidelines still can’t agree on whether to recommend it.

What Laser Therapy Actually Does Inside a Joint

The clinical term is photobiomodulation, which replaced the older “low-level laser therapy” (LLLT) label because the field now includes LEDs alongside true lasers. The basic idea is that specific wavelengths of red or near-infrared light, when absorbed by cells, trigger a cascade of biological responses. The primary target appears to be an enzyme in the mitochondria called cytochrome c oxidase. When light hits this enzyme, it enhances the production of nitric oxide and boosts the cell’s energy output. Research has shown that irradiation increases nitric oxide synthesis in an intensity-dependent manner, with the effect particularly strong at wavelengths around 590 nanometers and under low-oxygen conditions common in inflamed tissue.¹

That nitric oxide release matters because it dilates blood vessels, improves local circulation, and feeds into signaling pathways that reduce inflammation. In animal models of acute joint inflammation, laser treatment lowered levels of key inflammatory molecules including IL-1β and IL-6, which are the same cytokines that drive cartilage destruction and swelling in arthritic joints.² A separate study on induced arthritis found that cytokine levels decreased after laser treatment and that the therapy appeared to accelerate the resolution of inflammation through direct effects on immune cells.³

There is also a direct effect on pain signaling. A systematic review of both human and animal studies found that laser irradiation slowed nerve conduction velocity and reduced the amplitude of nerve action potentials in the majority of experiments. In human studies, pulsed or continuous wave light achieved this effect in 13 out of 18 trials. The proposed mechanism involves disruption of microtubule structures within nerve fibers, essentially turning down the volume on pain signals traveling to the brain.⁴

The Evidence for Knee Osteoarthritis

Knee osteoarthritis has attracted the most research, and the pooled results are cautiously positive. A meta-analysis of randomized, placebo-controlled trials found that laser therapy reduced pain by about 14 mm on a 100-mm visual analog scale compared with sham treatment at the end of therapy. During follow-up visits one to twelve weeks later, the benefit held at roughly 16 mm. When the analysis was restricted to studies that used recommended dose parameters, the effect grew to about 19 mm at end of treatment and peaked at around 32 mm during follow-ups two to four weeks after the final session. Disability scores also improved, and no adverse events were reported.⁵

To put those numbers in context, a 14-mm improvement on a 100-mm pain scale is noticeable but modest. A 32-mm improvement at peak effect, however, is in the range that patients consider genuinely meaningful. The gap between those two figures is almost entirely explained by whether the study used the right dose, which turns out to be the central problem in the field. A recent randomized controlled trial confirmed these patterns: patients receiving active photobiomodulation showed significant improvements in pain, stiffness, and functional limitations, while sham and control groups did not.⁶

The story for other joints is thinner. Hand, hip, and spine osteoarthritis have far fewer high-quality trials, and the results that do exist tend to be more mixed. Part of the issue is that deeper joints receive less light energy because tissue absorbs photons as they travel. Near-infrared wavelengths penetrate further than red wavelengths, but even so, reaching the hip joint through layers of muscle and fat is a different challenge than treating a relatively superficial knee.⁷

What About Rheumatoid Arthritis?

Rheumatoid arthritis is a different beast. It is driven by autoimmune inflammation rather than wear-and-tear degeneration, so the question is whether damping down local inflammatory signals with light has any lasting impact on a systemic disease. A 2024 meta-analysis pooling data from multiple placebo-controlled trials found that laser therapy significantly improved grip strength in RA patients, with the treated groups outperforming placebo by a meaningful margin. Morning stiffness also decreased significantly in the laser groups compared with sham treatment.⁸

Those results sound encouraging, but the researchers flagged high variability across studies. Treatment protocols differed widely, patient populations weren’t always comparable, and the benefits of laser therapy for RA should be understood as supplemental to disease-modifying drugs, not a replacement. Nobody in the rheumatology world is suggesting you skip methotrexate in favor of a laser. The value, if it holds up, is in managing symptoms like morning stiffness and hand weakness that medications don’t always fully control.

Animal research has explored combining laser therapy with resistance exercise for RA, finding that the combination restored muscle strength and improved joint structure more effectively than either treatment alone.⁹ That’s a rat study, so it doesn’t translate directly to humans, but it suggests that laser therapy may work best as part of a broader rehabilitation approach rather than as a standalone treatment.

The Placebo Problem

Laser therapy trials face a unique challenge with placebo effects. The treatment involves a warm, futuristic-looking device applied by a health professional in a clinical setting, and the patient can’t easily tell whether the device is actually emitting therapeutic light or is switched to a sham mode. That combination produces a strong placebo response. In one double-blinded knee osteoarthritis trial, the sham group showed genuine improvements in functional tests like walking time and stair climbing despite receiving no active treatment. The researchers attributed this to neurobiological mechanisms connecting environmental cues and medical interactions to symptom improvement.¹⁰

An older but striking trial in rheumatoid arthritis drove this point home. Patients received active laser on one hand and sham laser on the other, with neither the patient nor the clinician knowing which was which. Seventy-two percent of patients reported pain relief, but the reduction was equal in both hands, suggesting the entire benefit was a placebo effect.¹¹ That study used treatment parameters that would now be considered far below the recommended dose, which may explain the result. But it illustrates why the field has had such a hard time convincing skeptics: when your treatment has a powerful placebo component and the active dose window is narrow, sorting real effects from imagined ones takes exceptionally careful trial design.

The more recent placebo-controlled trials that do use appropriate doses consistently show the active laser group pulling ahead of sham, which is reassuring. But anyone considering the treatment should know that part of the benefit they experience in a clinic setting will come from the ritual of the treatment itself, and that’s not a bad thing. Placebo-driven improvements in pain and function are real improvements for the patient, even if they complicate the science.

Why Dose Is the Whole Ballgame

The single biggest reason laser therapy research has produced such mixed results is that different studies use wildly different doses, and the relationship between dose and effect is not linear. There is a well-documented biphasic response: too little light does nothing, a moderate amount stimulates healing and reduces inflammation, and too much actually inhibits cellular activity and can make things worse.¹²

Cell culture experiments have confirmed this pattern repeatedly. In one study of human fibroblasts, lower energy doses produced the highest mitochondrial activity and cell viability, while higher doses suppressed both measures.¹³ Similar biphasic behavior has been observed in tendon and bursa-derived cells, where moderate fluences boosted metabolic activity while lower fluences actually inhibited it in some cases.¹⁴ Even the anti-inflammatory effects depend on getting the parameters right: in one joint inflammation study, a 50-milliwatt treatment was better at reducing cellular inflammation and lowering certain cytokines, while a 100-milliwatt treatment was better at reducing a different cytokine, TNFα.²

This biphasic behavior means that a trial using suboptimal parameters can easily produce a null result, and that null result then gets pooled into meta-analyses alongside properly dosed trials, dragging the average effect size down. It’s as if you were running a drug trial where half the studies accidentally used the wrong dosage and then concluded the drug was only marginally effective. The meta-analysis of knee osteoarthritis trials showed exactly this pattern: the overall effect was modest, but studies using recommended doses produced effects more than twice as large.

High-Intensity Versus Low-Level Laser

The traditional approach uses low-power lasers or LEDs, typically in the range of tens to hundreds of milliwatts. A newer approach uses high-intensity laser therapy (HILT), which delivers watts rather than milliwatts in short pulses. The idea is to push more photons deeper into tissue without overheating the surface. Head-to-head comparisons are starting to accumulate, and they consistently favor the high-intensity version.

A 2023 randomized, double-blind trial compared both approaches alongside exercise therapy for knee osteoarthritis. Both laser groups improved, but the high-intensity group showed improvements roughly 50% greater for pain scores and 20% greater for knee-related disability compared to the low-level group. Only the high-intensity group crossed clinically meaningful thresholds for disability improvement.¹⁵ A separate trial published in 2025 reached similar conclusions, with the high-intensity group achieving significantly better pain, function, and range-of-motion scores at six weeks, though cartilage thickness measurements were no different between the two groups.¹⁶

High-intensity laser treatment has also shown durability. One trial found that the pain reduction achieved with high-intensity therapy was preserved at both one-month and three-month follow-ups, and that patients showed improved weight distribution between their affected and unaffected legs, suggesting a genuine functional recovery rather than just pain masking.¹⁷ The catch is that high-intensity devices are expensive and available only in clinical settings. You won’t find a consumer version on Amazon.

Why Major Guidelines Still Hesitate

Despite the positive trial data, some prominent clinical guidelines recommend against laser therapy for arthritis. The 2018 Australian clinical guideline for knee osteoarthritis explicitly recommended against LLLT.¹⁸ A narrative review analyzing that guideline pointed out that the recommendation may not have adequately accounted for the dose-response issue: when trials using inappropriate parameters are weighed equally against properly dosed trials, the average effect looks underwhelming.

This tension between evidence and guidelines is common in physical therapy modalities. Guideline panels tend to want consistent, large-scale evidence before recommending a treatment, and the laser therapy literature still has too many underpowered studies using non-standard protocols. The field has also been hurt by a history of inflated marketing claims from device manufacturers and clinics, which makes guideline committees understandably cautious. The practical result is that insurance coverage for laser therapy is spotty in most countries, meaning patients often pay out of pocket.

Can Laser Therapy Actually Repair Cartilage?

This is where the research gets genuinely intriguing but also more preliminary. Photobiomodulation has gained attention as a potential tool for cartilage regeneration because it promotes cellular responses and reduces inflammation, both of which support repair processes.¹⁹ Lab experiments with human cartilage cells have shown that near-infrared light at 940 nanometers significantly increased the production of type II collagen and glycosaminoglycans, the structural building blocks of healthy cartilage.²⁰

The gap between cell culture results and clinical reality remains wide. Getting enough light energy into a weight-bearing joint to stimulate cartilage cells buried under layers of tissue is a different problem from shining a laser on cells in a dish. The head-to-head trials comparing high-intensity and low-level laser for knee osteoarthritis found no difference in femoral cartilage thickness between groups, suggesting that neither approach produced measurable structural changes over the study period. That doesn’t mean cartilage repair is impossible, just that it hasn’t been demonstrated yet in living patients with current protocols.

Home Devices and What to Watch For

The consumer market for at-home photobiomodulation devices has exploded, with products ranging from handheld laser pens to wrap-around LED pads. A systematic review of home-use photobiomodulation devices found that most studies reported positive results across a range of conditions, and that the devices generally delivered doses within the parameters recommended by the World Association for Photobiomodulation Therapy.²¹ That said, “mostly positive” in a small number of studies is a lower bar than you’d want before spending several hundred dollars.

The practical concerns with home devices are straightforward. Many consumer products use LEDs rather than true lasers, which spread light more diffusely and may deliver less energy to deeper tissues. Power output is often far below what clinical devices achieve, which matters given how sensitive the results are to dose. And the lack of professional guidance means users might treat the wrong area, use the device for too short or too long, or hold it at a distance that wastes most of the light energy. If you’re considering a home device, look for one that specifies its wavelength (typically 800 to 1000 nm for joint conditions), power output in milliwatts, and recommended treatment duration. Vague marketing language about “healing light” without technical specifications is a red flag.

Combining Laser With Other Treatments

One of the more promising research directions involves pairing laser therapy with other interventions. A pilot study explored combining intra-articular laser treatment with platelet-rich plasma injections in patients whose prior PRP treatments had failed. The researchers found that delivering laser light directly inside the joint, rather than through the skin surface, minimized the energy lost to tissue absorption, and that the combination appeared to produce synergistic effects greater than either treatment alone.²² The study was small and lacked a control group, so it’s far from definitive, but it points toward a logical evolution of the technology: rather than fighting the physics of getting light through skin and muscle, deliver it directly where it’s needed.

Exercise remains the most consistently recommended partner for laser therapy. Nearly every positive trial in the literature used laser alongside a structured exercise or physical therapy program. The studies comparing laser-plus-exercise to exercise alone generally show additional benefit from the laser component, but neither the trials nor the biology suggest that laser therapy works well in isolation. If you’re not also addressing strength, flexibility, and joint loading, the photons are doing their work on tissue that keeps getting re-damaged.

Safety and Who Should Be Cautious

The safety profile of laser therapy is one of its genuinely strong points. The meta-analysis of knee osteoarthritis trials reported no adverse events in the active treatment groups.⁵ Side effects that can occur with laser therapy more broadly, including skin irritation, temporary warmth, and rare instances of bleeding or infection at treatment sites, are typically associated with higher-powered surgical or ablative lasers rather than the low-level or even high-intensity pulsed devices used for arthritis.²³

Standard precautions include avoiding direct exposure to the eyes (both the patient and the clinician should wear appropriate protective eyewear), not treating over active cancerous lesions, and being cautious during pregnancy when treating areas near the uterus. People taking photosensitizing medications should discuss laser therapy with their physician first, as these drugs can amplify the skin’s reaction to light. Beyond those commonsense cautions, the treatment carries far fewer risks than the long-term use of nonsteroidal anti-inflammatory drugs, which remain the pharmacological mainstay of osteoarthritis pain management and carry their own well-documented gastrointestinal and cardiovascular risks.